Enzymatic Synthesis and Antimicrobial Activity of Oligomer Analogues of Medicinal Biopolymers from Comfrey and Other Species of the Boraginaceae Family
- PMID: 35057011
- PMCID: PMC8779701
- DOI: 10.3390/pharmaceutics14010115
Enzymatic Synthesis and Antimicrobial Activity of Oligomer Analogues of Medicinal Biopolymers from Comfrey and Other Species of the Boraginaceae Family
Abstract
This study reports the first enzymatic synthesis leading to several oligomer analogues of poly[3-(3,4-dihydroxyphenyl)glyceric acid]. This biopolymer, extracted from plants of the Boraginaceae family has shown a wide spectrum of pharmacological properties, including antimicrobial activity. Enzymatic ring opening polymerization of 2-methoxycarbonyl-3-(3,4-dibenzyloxyphenyl)oxirane (MDBPO) using lipase from Candida rugosa leads to formation of poly[2-methoxycarbonyl-3-(3,4-dibenzyloxyphenyl)oxirane] (PMDBPO), with a degree of polymerization up to 5. Catalytic debenzylation of PMDBPO using H2 on Pd/C yields poly[2-methoxycarbonyl-3-(3,4-dihydroxyphenyl)oxirane] (PMDHPO) without loss in molecular mass. Antibacterial assessment of natural polyethers from different species of Boraginaceae family Symhytum asperum, S. caucasicum,S. grandiflorum, Anchusa italica, Cynoglossum officinale, and synthetic polymers, poly[2-methoxycarbonyl-3-(3,4-dimethoxyphenyl)oxirane (PMDMPO) and PMDHPO, reveals that only the synthetic analogue produced in this study (PMDHPO) exhibits a promising antimicrobial activity against pathogenic strains S.aureus ATCC 25923 and E.coli ATCC 25922 the minimum inhibitory concentration (MIC) being 100 µg/mL.
Keywords: Boraginaceae family; antimicrobial activity; enzymatic polymerization; lipase; poly[3-(3,4-dihydroxyphenyl)glyceric acid].
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures






References
-
- Salehi B., Sharopov F., Tumer T.B., Ozleyen A., Rodríguez-Pérez C., Ezzat S.M., Azzini E., Hosseinabadi T., Butnariu M., Sarac I., et al. Symphytum species: A comprehensive review on chemical composition, food applications and phytopharmacology. Molecules. 2019;24:2272. doi: 10.3390/molecules24122272. - DOI - PMC - PubMed
-
- Araujo L.U., Reis P.G., Barbos L.C.O., Saude-Guimarгes D.A., Grabe-Guimarгes A., Mosqueira V.C.F., Carneiro C.M., Silva-Barcellos N.M. In vivo wound healing effects of Symphytum officinale L. leaves extract in different topical formulations. Pharmazie. 2012;67:355–360. doi: 10.1691/ph.2012.1563. - DOI - PubMed
-
- Al-Snafi A.E. The pharmacology of Anchusa italica and Anchusa strigosa. Int. J. Pharm. Pharm. Sci. 2014;6:7–10.
-
- Baghiani A., Boussoualim N., Trabsa H., Aouachria S., Arrar L. In vivo free radical scavenging, antihemolytic activity and antibacterial effects of Anchusa azurea extracts. Int. J. Med. Med. Sci. 2013;46:1113–1118.
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases